The Daily Pennsylvanian is a student-run nonprofit.

Please support us by disabling your ad blocker on our site.

400 patients will be treated in the trial to study if hydroxychloroquine can treat COVID-19.

All comments eligible for publication in Daily Pennsylvanian, Inc. publications.